반응 #60633

ord-8a6b5cd84c4a4679bc4fa08bef6346bc

반응 조건

상세 조건
See reaction.notes.procedure_details.

후처리

  1. 1
    세척the organic phase was washed in succession once each with 3 ml dilute aqueous KHSO4 solution and saturated aqueous common salt solution
  2. 2
    건조The organic phase was dried over magnesium sulfate
  3. 3
    기타the solvent was largely evaporated at reduced pressure
  4. 4
    기타the remaining residue was chromatographed on silica gel (mobile phase: EA/cyclohexane 2:1 v/v)
  5. 5
    기타Drying the product fractions in an oil pump vacuum

실험 절차

300 mg 2-{[1-({[(3S)-1-(2-tert.butoxy-2-oxoethyl)-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-3-yl]amino}-carbonyl)cyclopentyl]methyl}-4-(isopropylamino)-4-oxobutyric acid (for preparation see Example 12) was dissolved in 5 ml dichloromethane. 33 mg DMAP, 74 μl methoxyethoxymethyl chloride and 90 μl triethylamine were added to this receiving solution. The reaction mixture was stirred overnight, then diluted with 5 ml dichloromethane and the organic phase was washed in succession once each with 3 ml dilute aqueous KHSO4 solution and saturated aqueous common salt solution. The organic phase was dried over magnesium sulfate, the solvent was largely evaporated at reduced pressure and the remaining residue was chromatographed on silica gel (mobile phase: EA/cyclohexane 2:1 v/v). Drying the product fractions in an oil pump vacuum yielded 191 g of the title compound, MS: [M+H]+: 646; m/z: 590, 540, 484, 425.

출처

DOI: 10.6084/m9.figshare.5104873.v1특허: US07427611B2uspto-grants-2008_09